NIDDM – Type 2 Diabetes: Causes, Symptoms, Treatment
NIDDM (Non-Insulin-Dependent Diabetes Mellitus) is the older term for type 2 diabetes, a chronic metabolic disease characterized by elevated blood glucose levels.
Things worth knowing about "NIDDM"
NIDDM (Non-Insulin-Dependent Diabetes Mellitus) is the older term for type 2 diabetes, a chronic metabolic disease characterized by elevated blood glucose levels.
What is NIDDM?
NIDDM stands for Non-Insulin-Dependent Diabetes Mellitus and is the former medical term for the condition now widely known as type 2 diabetes mellitus. The designation was officially replaced by the World Health Organization (WHO) in the 1990s because it proved misleading in practice – many patients with this condition do eventually require insulin therapy as their disease progresses. NIDDM is one of the most prevalent chronic diseases worldwide and is defined by persistently elevated blood glucose levels (hyperglycemia) resulting from impaired insulin action or secretion.
Causes
The disease arises from a combination of genetic predisposition and lifestyle-related factors. Two core mechanisms are involved:
- Insulin resistance: Body cells become less responsive to insulin, preventing adequate glucose uptake from the bloodstream.
- Beta-cell dysfunction: The pancreas gradually loses its ability to produce sufficient insulin to compensate for the resistance.
Key risk factors include:
- Overweight and obesity (especially abdominal fat)
- Physical inactivity
- Unhealthy dietary habits
- Family history of diabetes (genetic predisposition)
- Older age (risk increases significantly after age 45)
- History of prediabetes or gestational diabetes
Symptoms
NIDDM typically develops slowly over many years. In the early stages, many individuals experience few or no noticeable symptoms. Common signs may include:
- Excessive thirst and frequent urination
- Unexplained fatigue and lethargy
- Blurred vision
- Slow-healing wounds or sores
- Recurrent infections (e.g., urinary tract or skin infections)
- Tingling, numbness, or pain in the hands and feet
Diagnosis
Diagnosis is established through blood tests. The following tests are used in clinical practice:
- Fasting plasma glucose: A value of ≥ 126 mg/dL (7.0 mmol/L) on two separate occasions is diagnostic.
- HbA1c (glycated hemoglobin): A level of ≥ 6.5% indicates diabetes.
- Oral glucose tolerance test (OGTT): Blood glucose measured 2 hours after ingesting a standard glucose load; a value of ≥ 200 mg/dL confirms diabetes.
- Random plasma glucose: A value of ≥ 200 mg/dL in the presence of classic symptoms is sufficient for diagnosis.
Treatment
Management of NIDDM (type 2 diabetes) is individualized and follows a stepwise approach depending on disease severity and patient profile.
Lifestyle Modifications
Lifestyle changes form the cornerstone of treatment:
- Weight reduction through a balanced, low-glycemic, fiber-rich diet
- Regular physical activity (at least 150 minutes of moderate-intensity exercise per week)
- Smoking cessation and reduction of alcohol consumption
Pharmacological Therapy
When lifestyle changes alone are insufficient, medications are prescribed:
- Metformin: First-line medication that improves insulin sensitivity and reduces hepatic glucose production
- SGLT-2 inhibitors (e.g., empagliflozin): Promote urinary glucose excretion and offer cardiovascular benefits
- GLP-1 receptor agonists (e.g., semaglutide): Enhance insulin secretion, reduce appetite, and support weight loss
- Sulfonylureas, DPP-4 inhibitors, insulin: Additional options used depending on disease progression
Long-Term Complications
Poorly controlled or untreated type 2 diabetes can lead to serious complications, including:
- Cardiovascular disease (heart attack, stroke)
- Diabetic nephropathy (kidney damage leading to chronic kidney disease)
- Diabetic retinopathy (retinal damage with risk of blindness)
- Diabetic foot syndrome (impaired wound healing, risk of amputation)
- Peripheral neuropathy (nerve damage causing pain or numbness)
References
- World Health Organization (WHO): Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. WHO Press, Geneva, 2006.
- American Diabetes Association (ADA): Standards of Medical Care in Diabetes 2024. Diabetes Care, 47(Suppl. 1), 2024.
- Zheng, Y., Ley, S. H., Hu, F. B.: Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology, 14(2), 88–98, 2018.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.